Table 2.
Angiographic and Procedural Characteristics
| 2019 (n = 3,484) | 2020 (n = 2,811) | p Value | |
|---|---|---|---|
| Radial access | 2,945 (84.5) | 2,419 (86.1) | 0.09 |
| Culprit vessel | 0.30 | ||
| Left main | 70 (2.0) | 52 (1.8) | |
| Left anterior descending artery | 1,590 (45.6) | 1,264 (45.0) | |
| Circumflex | 484 (13.9) | 438 (15.6) | |
| Right coronary artery | 1,312 (37.8) | 1,029 (36.6) | |
| Anterolateral branch | 11 (0.2) | 6 (0.2) | |
| SVG | 17 (0.5) | 22 (0.8) | |
| Lesion location | 0.78 | ||
| Proximal | 1,732 (49.7) | 1,395 (49.6) | |
| Mid | 1,386 (39.8) | 1,134 (40.4) | |
| Distal | 366 (10.5) | 281 (10.0) | |
| In-stent thrombosis | 150 (4.3) | 128 (4.6) | 0.63 |
| Multivessel disease | 1,594 (45.8) | 1,346 (47.9) | 0.092 |
| Pre-procedural TIMI flow grade 0 | 2,114 (60.7) | 1,754 (62.4) | 0.16 |
| Thrombectomy | 652 (18.7) | 489 (17.4) | 0.17 |
| Stenting | 3,190 (91.6) | 2,589 (92.1) | 0.44 |
| Drug-eluting stent | 3,157 (90.6) | 2,607 (92.7) | 0.003 |
| Post-procedural TIMI flow grade 3 | 3,212 (92.2) | 2,567 (91.3) | 0.21 |
| Group IIb/IIIa inhibitors/cangrelor | 776 (22.3) | 671 (23.9) | 0.13 |
| Bivalirudin | 24 (0.7) | 11 (0.4) | 0.11 |
| Additional PCI | 0.12 | ||
| During the index procedure | 500 (14.4) | 442 (15.7) | |
| Staged | 415 (11.9) | 361 (12.8) | |
| DAPT therapy | 3,453 (99.0) | 2,777 (98.8) | 0.21 |
Values are n (%).
DAPT = dual antiplatelet therapy; PCI = percutaneous coronary intervention; SVG = saphenous vein graft; TIMI = Thrombolysis In Myocardial Infarction.